Plastic Surgery-on-a-Chip: Organ-on-a-Chip Applications in Plastic and Reconstructive Surgery
Journal of Reconstructive Microsurgery · 19.03.2026
DOI: 10.1055/a-2824-6073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reconstructive Microsurgery, erschienen am 19.03.2026. Verfasst von Aryan Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States.
Abstract (Originalsprache)
Background
Organ-on-a-chip (OoC) platforms are microfluidic systems that replicate key aspects of human tissue physiology in controlled environments. Originally developed for drug testing and disease modeling, they provide a more human-specific and reproducible alternative to traditional preclinical models, which often fail to capture the complexity of tissues relevant to plastic and reconstructive surgery.
Methods
This review synthesizes current OoC technologies with direct application to plastic and reconstructive surgery, focusing on skin-, vessel-, adipose-, and nerve-on-a-chip systems. The analysis emphasizes how these platforms model tissue structure, function, and interactions and evaluates their ability to simulate clinically relevant processes.
Results
Skin-on-a-chip platforms enable dynamic modeling of wound healing, graft integration, and barrier function. Vessel-on-a-chip systems replicate microcirculatory flow, endothelial function, and vascular wall behaviors, supporting studies of flap viability and ischemia-reperfusion injury. Adipose-on-a-chip preserves lipid metabolism and inflammatory signaling, informing research into fat graft retention and remodeling. Nerve-on-a-chip platforms allow real-time monitoring of nerve injury and regeneration, aiding evaluation of nerve repair and graft performance. Across these systems, OoC models provide more clinically relevant insights than animal or static in vitro approaches, though limitations persist, including restricted physiological complexity, lack of platform standardization, short-term viability, and scalability challenges.
Conclusion
OoC platforms offer significant promise for advancing plastic and reconstructive surgery research by bridging translational gaps and aligning in vitro modeling with surgical outcomes such as graft take and nerve function. Future directions include incorporating immune elements, developing multitissue systems, expanding commercial accessibility, and improving long-term functionality. As these technologies mature, they have the potential to accelerate innovation and improve patient outcomes in reconstructive surgery.
Autor:innen und Institutionen
- Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States.
- Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts, United States.
- Division of Cardiovascular Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania, United States.
Zitieren
APA
Gupta, A., Zhang, Y. S., & Mokashi, S. (2026). Plastic Surgery-on-a-Chip: Organ-on-a-Chip Applications in Plastic and Reconstructive Surgery. Journal of Reconstructive Microsurgery. https://doi.org/10.1055/a-2824-6073
Vancouver
Gupta A, Zhang YS, Mokashi S. Plastic Surgery-on-a-Chip: Organ-on-a-Chip Applications in Plastic and Reconstructive Surgery. Journal of Reconstructive Microsurgery. 2026. doi:10.1055/a-2824-6073
BibTeX
@article{Gupta2026,
author = {Gupta, Aryan and Zhang, Yu Shrike and Mokashi, Suyog},
title = {Plastic Surgery-on-a-Chip: Organ-on-a-Chip Applications in Plastic and Reconstructive Surgery},
journal = {Journal of Reconstructive Microsurgery},
year = {2026},
doi = {10.1055/a-2824-6073}
}
EUVIMED